Erick Riquelme
- Cancer Research top 10%
-
- Epigenetics and DNA Methylation 7
- Gut microbiota and health 5
- RNA modifications and cancer 4
- Cancer-related gene regulation 3
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
- Agronomy and Crop Science top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- Cancer Research and Treatments 5
-
- Hormonal Regulation and Hypertension 3
Erick Riquelme
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 230
- Molecular Biology 628
- Oncology 237
- Biological Psychiatry 18
- Agronomy and Crop Science 62
Countries citing papers authored by Erick Riquelme
This map shows the geographic impact of Erick Riquelme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erick Riquelme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erick Riquelme more than expected).
Fields of papers citing papers by Erick Riquelme
This network shows the impact of papers produced by Erick Riquelme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erick Riquelme. The network helps show where Erick Riquelme may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erick Riquelme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 32 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 1 | |
| 9 | 2020 | 12 | |
| 10 | 2015 | 85 | |
| 11 | 2014 | 59 | |
| 12 | 2014 | 79 | |
| 13 | 2013 | 123 | |
| 14 | 2012 | 34 | |
| 15 | 2011 | 51 | |
| 16 | 2010 | 45 | |
| 17 | 2009 | 24 | |
| 18 | 2007 | 9 | |
| 19 | 2007 | 40 | |
| 20 | 2004 | 48 |
About Erick Riquelme
Erick Riquelme is a scholar working on Biotechnology, Oncology, Toxicology, Immunology and Molecular Biology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Gut microbiota and health (5 papers), Cancer Research and Treatments (5 papers), RNA modifications and cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer-related gene regulation (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (628 citations), Oncology (237 citations), Biological Psychiatry (18 citations) and Agronomy and Crop Science (62 citations). Erick Riquelme has collaborated with scholars based in Chile, United States and Netherlands. Frequent co-authors include Ignacio I. Wistuba, Heather Lin, Alexis M. Kalergis, Carmen Behrens, J. Jack Lee, George R. Simon, Adi F. Gazdar, Rodrigo Pacheco, César A. Moran and Neda Kalhor. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Cancer Biology & Therapy, Experimental Neurology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.